Efficacy of Pegylated Interferon on Liver Fibrosis in Co-infected Patient With HIV and Hepatitis C
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to prove the efficacy of peginterferon in HIV infected patients with
liver disease caused by hepatitis C virus (HCV) when the treatment to eradicate the virus
failed. This scientific proof needs a comparative study to be done including two groups of
patients randomly allocated: one with the treatment (peginterferon) and the other without any
treatment against HCV with a duration of 2 years. To conclude, two liver biopsies are needed;
one before the study and a second 2 years after.
Phase:
Phase 3
Details
Lead Sponsor:
French National Agency for Research on AIDS and Viral Hepatitis